Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Curr Cancer Drug Targets ; 7(6): 582-90, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17896923

ABSTRACT

Subsequent to an initiating event, tumor promotion requires sustained cell proliferation to allow for progressive accumulation of pro-oncogenic mutations. The unique characteristics of stem cells would seem to implicate these cells as particularly suitable targets for carcinogens. Several lines of evidence suggest that tumors harbor a small population of cancer stem cells (CSC) which both give rise to the bulk of the tumor and are tumorigenic in experimental models. Mounting evidence suggests that these cells are responsible for re-growth of a tumor following unsuccessful treatment and for the establishment of metastases. The concept of CSC has been demonstrated in several human cancers including leukemia, breast, prostate, lung, and brain tumors. Taken together, the properties of CSC suggest that they are appropriate targets for cancer therapies. Such treatments would require a deep understanding of the CSC origin, molecular profile, and interaction with the local microenvironment. This report will summarize what is currently known regarding CSC, with particular emphasis on hepatic cancers, the cellular origin of liver tumors, and the role of liver stem cells and their niche in hepatocarcinogenesis.


Subject(s)
Liver Neoplasms/pathology , Neoplasms/pathology , Stem Cells/cytology , Humans
2.
Curr Pharm Biotechnol ; 8(3): 167-75, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17584089

ABSTRACT

Stem cells represent the key to tissue genesis, regeneration, and turnover. This notion has spawned the concept of regenerative medicine, or stem cell based therapies to supplement degenerating or damaged tissues. However, stem cells may also represent a preferential target of carcinogens. The unique ability of stem cells to self-renew and to differentiate into multiple phenotypes implies that all stem cells share a common transcriptional signature. A better knowledge of the stem cell transcriptome appears to be fundamental to fully achieve the potential of regenerative medicine, and may lead to new strategies for cancer prevention and treatment. Elucidation of the transcriptional programming and molecular mechanisms which direct stem cell self-renewal, differentiation, and tumorigenesis should provide key insights into deciphering exactly how "stemness" is maintained, as well as the molecular basis of cell plasticity and cancer development. cDNA and oligonucleotide microarrays are the most accessible transcriptome profiling methods to date, providing the unique opportunity to compare global gene expression patterns among different cell populations. Microarray technologies have been applied to three major areas of stem cell research: maintenance of pluripotency, development of uniform and regulated differentiation, and microenvironment analyses. The aim of the present review is to summarize state-of-the-art transcriptional profiling of different stem cell lines, cancer stem cells, and the niches these cells occupy in vivo.


Subject(s)
Gene Expression Profiling/methods , Oligonucleotide Array Sequence Analysis/methods , Proteome/metabolism , Stem Cells/classification , Stem Cells/metabolism , Transcription Factors/metabolism , Animals , Biomarkers/metabolism , Cell Line/metabolism , Humans
3.
Gut ; 52(7): 1060-7, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12801967

ABSTRACT

BACKGROUND AND AIM: Liver regeneration after severe liver damage depends in part on proliferation and differentiation of hepatic progenitor cells (HPCs). Under these conditions they must be able to withstand the toxic milieu of the damaged liver. ATP binding cassette (ABC) transporters are cytoprotective efflux pumps that may contribute to the preservation of these cells. The aim of this study was to determine the ABC transporter phenotype of HPCs. METHODS: HPC activation was studied in rats treated with 2- acetylaminofluorene (2-AAF) followed by partial hepatectomy (PHx). ABC transporter gene expression was determined by real time detection reverse transcription-polymerase chain reaction in isolated HPCs, hepatocytes, cholangiocytes, and cultured progenitor cell-like RLF phi 13 cells and by immunohistochemistry of total liver samples. ABC transporter efflux activity was studied in RLF phi 13 cells by flow cytometry. RESULTS: 2-AAF/PHx treated animals showed increased hepatic mRNA levels of the genes encoding multidrug resistance proteins Mdr1b, Mrp1, and Mrp3. Immunohistochemistry demonstrated expression of Mrp1 and Mrp3 proteins in periportal progenitor cells and of the Mdr1b protein in periportal hepatocytes. Freshly isolated Thy-1 positive cells and cultured RLF phi 13 progenitor cells highly expressed Mrp1 and Mrp3 mRNA while the hepatocyte specific transporters Mdr2, Bsep, Mrp2, and Mrp6 were only minimally expressed. Blocking Mrp activity by MK-571 resulted in accumulation of the Mrp specific substrate carboxyfluorescein in RLF phi 13 cells. CONCLUSION: HPCs express high levels of active Mrp1 and Mrp3. These may have a cytoprotective role in conditions of severe hepatotoxicity.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Liver/cytology , Stem Cells/metabolism , ATP Binding Cassette Transporter, Subfamily B/analysis , ATP-Binding Cassette Transporters/analysis , ATP-Binding Cassette Transporters/metabolism , Animals , Cell Division/physiology , Cell Line , Flow Cytometry/methods , Gene Expression , Genes, MDR/genetics , Immunohistochemistry/methods , Male , Multidrug Resistance-Associated Proteins/genetics , Polymerase Chain Reaction/methods , RNA, Messenger/analysis , Rats , Rats, Inbred F344 , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Specific Pathogen-Free Organisms
4.
Blood Cells Mol Dis ; 27(3): 590-600, 2001.
Article in English | MEDLINE | ID: mdl-11482872

ABSTRACT

Activation, proliferation, and differentiation of a distinct phenotype of cells, called oval cells, are observed after severe hepatic injuries in which the proliferation of existing hepatocytes is inhibited. Under those conditions, oval cells can act as bipotential progenitors of the two types of epithelial cells within the liver, hepatocytes and bile ductular cells. Oval cells are also believed to play a role in the hepatocellular carcinoma and cholangiocarcinoma development; although circumstantial data are available, no direct evidence exists to support this theory. Oval cells have usually been thought to be the progeny of an hepatic stem cell, native to the liver. Recently, however, we, as well as others, have obtained clear evidence that in the rodents, hepatic oval cells, or at least a fraction of them, can derive from a precursor cell of bone marrow origin. The rodent data have been supported by recent findings that human bone marrow cells are capable of becoming hepatocytes and cholangiocytes as well. Having shown that oval cells can be derived from an extrahepatic source, we now have the technology to address many unanswered questions in oval cell origin, fate, and physiology through the use of sex-mismatched bone marrow transplants.


Subject(s)
Hepatocytes/cytology , Stem Cells/cytology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/physiology , Cell Division/physiology , Cell Lineage/physiology , Humans , Liver/cytology , Liver/injuries , Liver/physiology , Stem Cells/physiology
5.
Anticancer Res ; 19(3A): 1635-40, 1999.
Article in English | MEDLINE | ID: mdl-10470094

ABSTRACT

BACKGROUND: Hepatocyte growth factor (HGF) is a multifunctional peptide that binds to a specific receptor, c-met. Both HGF and c-met have been identified in normal brain and on glial tumors. The purpose of this study is to further define the biologic importance of HGF and c-met on normal and malignant glial cells grown in vitro. MATERIALS AND METHODS: Nine human malignant glioma-derived tumor cell cultures and cultures of astrocytes derived from normal brain were examined for c-met and HGF transcripts using Northern blot or RT-PCR analysis. Cellular invasiveness was quantitated by mechanical assay and mitogenesis was determined by cell count. RESULTS: C-met was expressed in five of seven malignant glioma-derived tumor cell cultures and in both normal astrocyte cultures. HGF transcript was not detected in any of the cell cultures. HGF supplementation enhanced invasiveness in c-met positive cell lines and did not alter cellular mitogenesis in the assayed cultures. CONCLUSIONS: These findings suggest that HGF is a potent stimulator of invasiveness in c-met positive malignant glioma-derived tumor cells and is not an active cytokine with regards to in vitro glial cell proliferation. HGF may therefore stimulate glioma cellular invasion in vivo through binding to its receptor and by activating tyrosine kinase secondary messengers.


Subject(s)
Astrocytes/chemistry , Astrocytoma/chemistry , Brain Neoplasms/chemistry , Hepatocyte Growth Factor/analysis , Neoplasm Proteins/analysis , Neoplastic Stem Cells/chemistry , Nerve Tissue Proteins/analysis , Proto-Oncogene Proteins c-met/analysis , Adolescent , Adult , Aged , Astrocytoma/pathology , Brain Neoplasms/pathology , Cell Division/drug effects , Female , Glioblastoma/chemistry , Glioblastoma/pathology , Hepatocyte Growth Factor/pharmacology , Humans , Male , Middle Aged , RNA, Messenger/analysis , RNA, Neoplasm/analysis , Tumor Cells, Cultured/drug effects
6.
Cancer Res ; 59(16): 3954-60, 1999 Aug 15.
Article in English | MEDLINE | ID: mdl-10463591

ABSTRACT

Liver regeneration after partial hepatectomy (PHx) of the liver serves as a model for studying normal growth factor signals that become aberrant in cancer. Growth factor signals that may play a role in initiating the proliferation of hepatocytes after 70% PHx in the rat were investigated immediately after surgical resection of the liver. Presumptive activity was evaluated by determining the tyrosine phosphorylation state of receptors for epidermal growth factor (EGF) and hepatocyte growth factor (HGF) in the liver after PHx and after sham operation as a control. Under these conditions, it was determined that the EGF receptor was constitutively phosphorylated. EGF receptor tyrosine phosphorylation, however, was increased over basal levels by 60 min after resection. The HGF receptor, c-Met, was minimally phosphorylated in control livers, but a biphasic increase in phosphorylation was observed at 1-5 min after PHx and 60 min postsurgery. A slight increase in c-Met phosphorylation was observed in the sham-operated livers, but the signal was significantly less when compared with that in resected livers. Furthermore, 1 min after PHx, but not sham operation, urokinase-type plasminogen activator (u-PA) and u-PA receptor were observed in the immunoprecipitates of c-Met. Signaling downstream of growth factor receptor activation was also examined. There were no discernible phosphorylation changes in focal adhesion kinase during the early events after surgery in PHx; however, a rapid and sustained increase in the tyrosine phosphorylation of paxillin beginning 1 min after PHx, and a gradual increase in the phosphorylation beginning 5 min postsham operation, were observed. Changes in the activated state of the small GTP-binding protein Rho A and its associated proteins were seen but only after 3 h after PHx. The results indicate that HGF-related signal transduction cascades, which contribute to hepatocyte proliferation, are initiated within one min after PHx.


Subject(s)
Liver Regeneration , Liver/physiology , Signal Transduction/physiology , Animals , Epidermal Growth Factor/physiology , ErbB Receptors/physiology , Hepatectomy , Hepatocyte Growth Factor/physiology , Male , Phosphorylation , Proto-Oncogene Proteins c-met/physiology , Rats , Rats, Inbred F344 , Time Factors
7.
Science ; 284(5417): 1168-70, 1999 May 14.
Article in English | MEDLINE | ID: mdl-10325227

ABSTRACT

Bone marrow stem cells develop into hematopoietic and mesenchymal lineages but have not been known to participate in production of hepatocytes, biliary cells, or oval cells during liver regeneration. Cross-sex or cross-strain bone marrow and whole liver transplantation were used to trace the origin of the repopulating liver cells. Transplanted rats were treated with 2-acetylaminofluorene, to block hepatocyte proliferation, and then hepatic injury, to induce oval cell proliferation. Markers for Y chromosome, dipeptidyl peptidase IV enzyme, and L21-6 antigen were used to identify liver cells of bone marrow origin. From these cells, a proportion of the regenerated hepatic cells were shown to be donor-derived. Thus, a stem cell associated with the bone marrow has epithelial cell lineage capability.


Subject(s)
Bone Marrow Cells/cytology , Liver Regeneration , Liver/cytology , Nuclear Proteins , Stem Cells/cytology , Transcription Factors , 2-Acetylaminofluorene/pharmacology , Animals , Bone Marrow Transplantation , Carbon Tetrachloride/pharmacology , Cell Differentiation , Cell Division , DNA-Binding Proteins/genetics , Dipeptidyl Peptidase 4/metabolism , Epithelial Cells/cytology , Female , Hematopoietic Stem Cells/cytology , In Situ Hybridization , Liver/drug effects , Liver/physiology , Liver Transplantation , Male , Polymerase Chain Reaction , Rats , Rats, Inbred F344 , Rats, Inbred Lew , Sex-Determining Region Y Protein , Y Chromosome
8.
Hepatology ; 27(4): 1030-8, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9537443

ABSTRACT

Administration of 2-acetylaminofluorene (2-AAF) given before partial hepatectomy (PHx) results in suppression of hepatocyte proliferation and stimulation of oval cell proliferation. Our objective in this study was to examine the oval cell response and associated alpha-fetoprotein (AFP) gene expression by combining 2-AAF with selective damage of centrilobular regions (carbon tetrachloride [CCl4]) or periportal regions (allyl alcohol [AA]). Centrilobular damage results in a more enhanced oval cell response and AFP gene expression than periportal damage. Conversely, more intense proliferation of intraportal bile duct epithelia was seen with 2-AAF/AA than with 2-AAF/CCl4. The oval cell response and AFP gene expression was ranked as 2-AAF/ CCl4 > or = 2-AAF/PHx > 2-AAF/AA. AFP mRNA expression was also examined in an acute AA and CCl4 injury. We found very little AFP gene expression compared with the 2-AAF/hepatic injury models. To see a true oval cell response, the hepatocytes must be inhibited from proliferating. In addition, the results presented with the 2-AA/AA model suggest that the periportal matrix may be as important as the cells that populate the area.


Subject(s)
Liver/drug effects , Liver/pathology , 2-Acetylaminofluorene/toxicity , Animals , Carbon Tetrachloride/toxicity , Cell Division/drug effects , DNA/biosynthesis , Lethal Dose 50 , Male , Propanols/toxicity , RNA, Messenger/analysis , Rats , Rats, Inbred F344 , alpha-Fetoproteins/genetics
9.
Hepatology ; 27(2): 433-45, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9462642

ABSTRACT

Hepatic oval cells (HOC) are a small subpopulation of cells found in the liver when hepatocyte proliferation is inhibited and followed by some type of hepatic injury. HOC can be induced to proliferate using a 2-acetylaminofluorene (2-AAF)/hepatic injury (i.e., CCl4, partial hepatectomy [PHx]) protocol. These cells are believed to be bipotential, i.e., able to differentiate into hepatocytes or bile ductular cells. In the past, isolation of highly enriched populations of these cells has been difficult. Thy-1 is a cell surface marker used in conjunction with CD34 and lineage-specific markers to identify hematopoietic stem cells. Thy-1 antigen is not normally expressed in adult liver, but is expressed in fetal liver, presumably on the hematopoietic cells. We report herein that HOC express high levels of Thy-1. Immunohistochemistry revealed that the cells expressing Thy-1 were indeed oval cells, because they also expressed alpha-fetoprotein (AFP), gamma-glutamyl transpeptidase (GGT), cytokeratin 19 (CK-19), OC.2, and OV-6, all known markers for oval cell identification. In addition, the Thy-1+ cells were negative for desmin, a marker specific for Ito cells. Using Thy-1 antibody as a new marker for the identification of oval cells, a highly enriched population was obtained. Using flow cytometric methods, we isolated a 95% to 97% pure Thy-1+ oval cell population. Our results indicate that cell sorting using Thy-1 could be an attractive tool for future studies, which would facilitate both in vivo and in vitro studies of HOC.


Subject(s)
Liver/metabolism , Thy-1 Antigens/metabolism , 2-Acetylaminofluorene/pharmacology , Animals , Antibodies, Monoclonal/analysis , Biomarkers/analysis , Bromodeoxyuridine/analysis , Carbon Tetrachloride/pharmacology , Flow Cytometry , Fluorescent Antibody Technique, Indirect , Hepatectomy , Immunohistochemistry , Keratins/metabolism , Liver/chemistry , Liver/cytology , Liver/drug effects , Male , Proliferating Cell Nuclear Antigen/analysis , Rats , Rats, Inbred F344 , alpha-Fetoproteins/metabolism , gamma-Glutamyltransferase/analysis
10.
Am J Pathol ; 151(4): 905-9, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9327722

ABSTRACT

Administration of 2-acetylaminofluorene (2-AAF) given before a two-thirds partial hepatectomy (PHx), results in suppression of hepatocyte proliferation and stimulation of oval cell proliferation. Our objective in this study was to examine the oval cell response and associated alpha-fetoprotein (AFP) gene expression by combining 2-AAF with selective hepatic damage caused by either carbon tetrachloride (CCl4) exposure or by PHx. We also examined oval cell response with the above two protocols (2-AAF/CCl4 and 2-AAF/PHx) as affected by previous bile ductular damage caused by 4,4'-methylene dianiline (4,4'-diaminodiphenylmethane, DAPM) exposure. DAPM is an aromatic diamine, known to cause bile ductular damage in both humans and animals. Using the protocols of 2-AAF/ CCl4 and 2-AAF/PHx, when DAPM was given 24 hours before the hepatic injury, no oval cell proliferation was seen (histological) and AFP expression was not detected by Northern blot analysis. These results provide direct evidence that oval cells are closely associated with the biliary epithelial cells and supports the theory that hepatic oval cells may originate from cells derived from either intraportal or periportal ductules.


Subject(s)
Aniline Compounds/toxicity , Bile Ducts/drug effects , Carcinogens/toxicity , Cell Division/drug effects , Liver/cytology , 2-Acetylaminofluorene/pharmacology , Animals , Bile Ducts/pathology , Carbon Tetrachloride/pharmacology , Drug Interactions , Epithelium/drug effects , Epithelium/pathology , Hepatectomy , Lethal Dose 50 , Liver/drug effects , Male , Rats , Rats, Inbred F344 , alpha-Fetoproteins
11.
Brain Res Dev Brain Res ; 102(2): 299-303, 1997 Sep 20.
Article in English | MEDLINE | ID: mdl-9352114

ABSTRACT

Hepatocyte growth factor (HGF) was recently recognized as a potential neurotrophic factor in the developing brain. We studied expression of HGF and its receptor using Northern blot analysis and in situ hybridization for mRNA and double immunofluorescent laser confocal microscopy. HGF and cMet messages were abundant in the hippocampus of both human and rat brains. In this region, both messages were localized in the neuronal layer. Segregation of HGF predominantly in the hippocampal CA3-4 and cMet in CA1 supports the hypothesis that HGF may mediate important neurotrophic functions in both developing and adult brains.


Subject(s)
Brain/metabolism , Hepatocyte Growth Factor/biosynthesis , Proto-Oncogene Proteins c-met/biosynthesis , Animals , Brain/cytology , Brain/growth & development , Hippocampus/metabolism , Humans , Microscopy, Confocal , Neurons/metabolism , Rats , Rats, Sprague-Dawley
13.
Hepatology ; 26(4): 896-904, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9328311

ABSTRACT

Previous studies have shown that activity of urokinase-type plasminogen activator (u-PA) increases very rapidly (within 1 minute) after partial hepatectomy. In view of the well-recognized roles of u-PA as one of the major initiators of the matrix proteolysis cascade and as an activator of plasminogen and hepatocyte growth factor (HGF), we studied matrix degradation in liver shortly after partial hepatectomy. The activation of plasminogen to plasmin following partial hepatectomy was examined by Western blot analysis, and a small increase in plasmin at approximately 15 minutes followed by a large elevation at approximately 3 to 6 hours after partial hepatectomy was detected. In addition, we found that fibrinogen, the major substrate for plasmin, begins to be degraded at approximately 15 to 30 minutes following partial hepatectomy. Using immunohistochemical staining, we detected that the distribution of fibrinogen in normal liver is localized to the perisinusoidal space surrounding the periportal region. A decreased distribution of fibrinogen in the periportal region was found by 15 minutes and continued through 24 hours following partial hepatectomy. In addition, the distribution of fibronectin in normal liver was localized to the perisinusoidal space surrounding the periportal and the pericentral regions. A strikingly decreased distribution of fibronectin in the periportal region was found at 5 minutes after partial hepatectomy. Furthermore, we observed that the protein levels of laminin, entactin, and fibronectin in an extracellular matrix (ECM)-enriched preparation decreased shortly after partial hepatectomy, and were restored later. No changes were observed with either vitronectin or the integrin chain alpha(v). In contrast to the protein levels of the ECM components, the messenger RNA (mRNA) levels of fibronectin, integrin chain beta1, and integrin chain alpha(v) gradually increased over 18 hours and then decreased thereafter. Taken together, these results suggest that rapid reorganization of selected ECM components are important for hepatocyte proliferation at the early stages of liver regeneration.


Subject(s)
Extracellular Matrix/metabolism , Liver Regeneration , Animals , Fibrinogen/metabolism , Fibrinolysin/metabolism , Fibronectins/genetics , Male , RNA, Messenger/analysis , Rats , Rats, Inbred F344
14.
Stem Cells ; 14(5): 592-602, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8888500

ABSTRACT

Hepatocyte growth factor (HGF) is a pleiotropic growth factor which, in addition to its mitogenic potency for primary hepatocytes, also has a role in the regulation of cell motility, cell growth and morphogenesis. In the present study, we show that c-met, the high-affinity receptor for HGF, is expressed on human cord blood (CB) CD34+ progenitor cells and CD34+Thy-1+ Lin-(lin-) cells. We have investigated the capacity of HGF to synergize with other growth factors to induce colony formation by CB CD34+ progenitor cells. CD34+ cells were cultured in semisolid medium containing serum with increasing concentrations of GM-CSF, G-CSF, macrophage colony-stimulating factor (M-CSF), stem cell factor (SCF), interleukin 3 (IL-3) and IL-11 alone or in combination with HGF. HGF acted as a potent synergist and enhanced, up to fourfold, colony formation induced by GM-CSF, G-CSF or M-CSF. HGF in combination with SCF, IL-3 or IL-11 did not induce proliferation of colony forming units-granulocyte macrophage (CFU-GM) above control levels. In serum-deprived cultures, HGF was only detectably synergistic with IL-11, and all other culture combinations showed no proliferation. To determine whether the stimulatory effect of IL-11 and the synergistic effect of HGF in the absence of serum could be attributed to the effect of these two cytokines on stem cells, IL-11-stimulated and unstimulated lin- cells were analyzed for expression of c-met. CD34+Thy-1+Lin- cells were positive for c-met, both in the presence and absence of IL-11 stimulation, and Northern analysis indicated that c-met RNA expression was upregulated in response to IL-11 compared to unstimulated controls. These results provide strong evidence for upregulation of the HGF receptor on primitive hematopoietic cells by IL-11, and for the synergistic role of HGF in colony formation by hematopoietic stem cells.


Subject(s)
Fetal Blood/cytology , Hepatocyte Growth Factor/pharmacology , Receptor Protein-Tyrosine Kinases/biosynthesis , Stem Cells/drug effects , Antigens, CD34/analysis , Blood Proteins/pharmacology , Blotting, Northern , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Culture Media, Serum-Free/pharmacology , Drug Synergism , Female , Flow Cytometry , Granulocyte Colony-Stimulating Factor/pharmacology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Hematopoiesis/drug effects , Humans , Immunohistochemistry , Interleukin-11/pharmacology , Macrophage Colony-Stimulating Factor/pharmacology , Proto-Oncogene Proteins c-met , RNA, Messenger/metabolism , Receptor Protein-Tyrosine Kinases/analysis , Receptor Protein-Tyrosine Kinases/genetics , Stem Cells/chemistry , Stem Cells/metabolism , Thy-1 Antigens/analysis , Up-Regulation/drug effects
15.
J Cell Biol ; 132(6): 1133-49, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8601590

ABSTRACT

Mature adult parenchymal hepatocytes, typically of restricted capacity to proliferate in culture, can now enter into clonal growth under the influence of hepatocyte growth factor (scatter factor) (HGF/SF), epidermal growth factor (EGF), and transforming growth factor alpha (TGFalpha) in the presence of a new chemically defined medium (HGM). The expanding populations of hepatocytes lose expression of hepatocyte specific genes (albumin, cytochrome P450 IIB1), acquire expression of markers expressed by bile duct epithelium (cytokeratin 19), produce TGFalpha and acidic FGF and assume a very simplified morphologic phenotype by electron microscopy. A major change associated with this transition is the decrease in ratio between transcription factors C/EBPalpha and C/EBPbeta, as well as the emergence in the proliferating hepatocytes of transcription factors AP1, NFkappaB. The liver associated transcription factors HNFI, HNF3, and HNF4 are preserved throughout this process. After population expansion and clonal growth, the proliferating hepatocytes can return to mature hepatocyte phenotype in the presence of EHS gel (Matrigel). This includes complete restoration of electron microscopic structure and albumin expression. The hepatocyte cultures however can instead be induced to form acinar/ductular structures akin to bile ductules (in the presence of HGF/SF and type I collagen). These transformations affect the entire population of the hepatocytes and occur even when DNA synthesis is inhibited. Similar acinar/ductular structures are seen in embryonic liver when HGF/SF and its receptor are expressed at high levels. These findings strongly support the hypothesis that mature hepatocytes can function as or be a source of bipotential facultative hepatic stem cells (hepatoblasts). These studies also provide evidence for the growth factor and matrix signals that govern these complex phenotypic transitions of facultative stem cells which are crucial for recovery from acute and chronic liver injury.


Subject(s)
Culture Media, Serum-Free , Epidermal Growth Factor/pharmacology , Hepatocyte Growth Factor/pharmacology , Liver/drug effects , Transforming Growth Factor alpha/pharmacology , Adult , Base Sequence , Biomarkers , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Lineage , Cells, Cultured , Collagen , Drug Combinations , Gene Expression Regulation/drug effects , Humans , Keratins/biosynthesis , Keratins/genetics , Laminin , Liver/cytology , Molecular Sequence Data , Morphogenesis/drug effects , Niacinamide/physiology , Phenotype , Proteoglycans , Proto-Oncogene Proteins c-met , Receptor Protein-Tyrosine Kinases/biosynthesis , Receptor Protein-Tyrosine Kinases/genetics , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transferrin/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...